Netherlands at a glance
- Population
- 18.1 million 2025
- Life expectancy at birth
- 82.0 years, 2024
- People aged 65 and over
- 20.9 % of people, 2025
- Health spending per person
- 6,845 US$ per person, 2024
- Doctors
- 3.88 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
Netherlands Drug Delivery Devices Market Industry Trends and Forecast to 2034: Segmented by (Route, Product, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$470.2 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $687.6 Mn | — | — |
| 2025 (base) | $726.8 Mn | +$39.2 Mn | — |
| 2026 (forecast) | $768.2 Mn | +$41.4 Mn | +5.7% |
| 2027 (forecast) | $812.0 Mn | +$43.8 Mn | +11.7% |
| 2028 (forecast) | $858.3 Mn | +$46.3 Mn | +18.1% |
| 2029 (forecast) | $907.2 Mn | +$48.9 Mn | +24.8% |
| 2030 (forecast) | $958.9 Mn | +$51.7 Mn | +31.9% |
| 2031 (forecast) | $1.01 Bn | +$54.7 Mn | +39.5% |
| 2032 (forecast) | $1.07 Bn | +$57.8 Mn | +47.4% |
| 2033 (forecast) | $1.13 Bn | +$61.1 Mn | +55.8% |
| 2034 (forecast) | $1.20 Bn | +$64.5 Mn | +64.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $726.8 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.20 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Route and product (see all) |
| Key players | BD (Becton, Dickinson), Gerresheimer, West Pharmaceutical Services, Ypsomed, Terumo Corporation and 1 more (see all) |
| Regulator in the Netherlands | IGJSource: Health and Youth Care Inspectorate (IGJ). Checked 19 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Drug delivery devices give medicine in a controlled way, such as injectors, inhalers, patches and infusion pumps.
Key segments of the drug delivery devices market include route (Injectable, Inhalation and Transdermal) and product (Auto-Injectors, Pen Injectors and Inhalers).
Rising numbers of people with diabetes, a shift to tools that track and deliver treatment automatically, and more insurance cover are driving the drug delivery devices market.
Connected devices, lower-priced sensors and new insulins and pills give the drug delivery devices market room to grow.
High costs for people without cover, price competition and uneven access to care in low-income countries hold back the drug delivery devices market.
The drug delivery devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need CE marking under the EU Medical Device Regulation (MDR); in the Netherlands, the Health and Youth Care Inspectorate (IGJ) oversees them.[1] Everyone must have basic health insurance from a private insurer, with a package set by law; the National Health Care Institute advises what it covers.[2]
[1] Health and Youth Care Inspectorate (IGJ). Checked 19 Nov 2026.
[2] National Health Care Institute (Zorginstituut Nederland). Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how drug delivery devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in the Netherlands.
What doctors and scientists are doing in Drug Delivery Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
Netherlands
Netherlands
Netherlands
Netherlands
Netherlands
Netherlands
Pharmaceuticals · Netherlands
Pharmaceuticals · Global
Healthcare Services · Global
Healthcare Services · Global
Healthcare Services · Global
Pharmaceuticals · Global